These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3263408)

  • 21. Quantification of fecal alpha 1-antitrypsin excretion for assessment of inflammatory bowel diseases.
    Becker K; Frieling T; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):65-70. PubMed ID: 9512970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.
    Karbach U; Ewe K; Bodenstein H
    Gut; 1983 Aug; 24(8):718-23. PubMed ID: 6603392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Appraisal of activity in Crohn's disease. Value of inflammatory tests, deconjugation tests and the absorption of bile salts and alpha l-antitrypsin clearance].
    Gillard C; Deflandre J; Brassinne A
    Acta Gastroenterol Belg; 1984; 47(3):309-16. PubMed ID: 6333769
    [No Abstract]   [Full Text] [Related]  

  • 24. Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Dig Dis Sci; 1994 Mar; 39(3):507-12. PubMed ID: 8131686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment of developmental criteria in Crohn's disease].
    Deflandre J
    Rev Med Liege; 1984 Dec; 39(23):846-53. PubMed ID: 6335279
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance (author's transl)].
    Florent C; L'Hirondel C; Desmazures C; Giraudeaux V; Bernier JJ
    Gastroenterol Clin Biol; 1981 Feb; 5(2):193-7. PubMed ID: 6970700
    [No Abstract]   [Full Text] [Related]  

  • 28. Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.
    Wright EK; De Cruz P; Gearry R; Day AS; Kamm MA
    Inflamm Bowel Dis; 2014 Sep; 20(9):1668-77. PubMed ID: 24918319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's disease.
    el Yamani J; Soudan B; Mizon C; Colombel JF; Balduyck M; Cortot A; Mizon J
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():418-21. PubMed ID: 1642448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis.
    Moran A; Jones A; Asquith P
    Scand J Gastroenterol; 1995 Apr; 30(4):356-60. PubMed ID: 7610352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
    Thomas DW; Sinatra FR; Merritt RJ
    Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
    Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.
    Karbach U; Ewe K; Dehos H
    Dig Dis Sci; 1985 Mar; 30(3):229-35. PubMed ID: 2857632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS
    Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
    Karbach U; Singe CC; Ewe K
    Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Crohn's disease activity and alpha 1-antitrypsin in faeces.
    Arndt B; Schürmann G; Betzler M; Herfarth C; Schmidt-Gayk H
    Lancet; 1992 Oct; 340(8826):1037. PubMed ID: 1357424
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases.
    Saitoh O; Matsumoto H; Sugimori K; Sugi K; Nakagawa K; Miyoshi H; Hirata I; Matsuse R; Uchida K; Ohshiba S
    Digestion; 1995; 56(1):67-75. PubMed ID: 7895935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.
    van der Sluys Veer A; Brouwer J; Biemond I; Bohbouth GE; Verspaget HW; Lamers CB
    Dig Dis Sci; 1998 Mar; 43(3):590-5. PubMed ID: 9539656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.